How PD-L1 Biomarker Test Results Impact Clinical Management of Lung Cancer

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs. Goeffrey Oxnard and Lauren Ritterhouse review how the results of PD-L1 testing influence the choices in first- or second-line immunotherapy or combination immunochemotherapy in patients with squamous or non-squamous non-small-cell lung cancer.

January 30, 2014

Personalized Medicine and Drug Development/Approval

Listen as Dr Agarwala presents how developments in personalized medicine will impact and change the way drugs are developed and approved.

September 20, 2013

The Value of Personalized Medicine

John Hennessy provides a few benefits of personalized medicine as it effects the ability to make better treatment choices earlier rather than later